A detailed history of Bahl & Gaynor Inc transactions in Steris PLC stock. As of the latest transaction made, Bahl & Gaynor Inc holds 6,809 shares of STE stock, worth $1.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,809
Previous 7,184 5.22%
Holding current value
$1.5 Million
Previous $1.58 Million 4.69%
% of portfolio
0.01%
Previous 0.01%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$213.51 - $247.14 $80,066 - $92,677
-375 Reduced 5.22%
6,809 $1.65 Million
Q2 2024

Aug 07, 2024

SELL
$199.01 - $236.0 $29,851 - $35,400
-150 Reduced 2.05%
7,184 $1.58 Million
Q1 2024

May 10, 2024

SELL
$213.53 - $236.03 $74,735 - $82,610
-350 Reduced 4.55%
7,334 $1.65 Million
Q4 2023

Feb 02, 2024

SELL
$197.44 - $227.52 $201,191 - $231,842
-1,019 Reduced 11.71%
7,684 $1.69 Million
Q3 2023

Nov 03, 2023

SELL
$217.85 - $233.02 $78,861 - $84,353
-362 Reduced 3.99%
8,703 $1.91 Million
Q2 2023

Aug 14, 2023

SELL
$181.84 - $224.98 $232,573 - $287,749
-1,279 Reduced 12.36%
9,065 $2.04 Million
Q1 2023

May 03, 2023

SELL
$176.39 - $220.86 $25,223 - $31,582
-143 Reduced 1.36%
10,344 $1.98 Million
Q4 2022

Feb 10, 2023

SELL
$160.98 - $199.08 $177,882 - $219,983
-1,105 Reduced 9.53%
10,487 $1.94 Million
Q3 2022

Nov 14, 2022

SELL
$160.72 - $225.65 $176,952 - $248,440
-1,101 Reduced 8.67%
11,592 $1.93 Million
Q2 2022

Aug 08, 2022

SELL
$192.78 - $252.92 $92,919 - $121,907
-482 Reduced 3.66%
12,693 $2.62 Million
Q1 2022

May 12, 2022

SELL
$215.16 - $247.18 $282,289 - $324,300
-1,312 Reduced 9.06%
13,175 $3.19 Million
Q4 2021

Feb 10, 2022

SELL
$206.02 - $245.17 $1,030 - $1,225
-5 Reduced 0.03%
14,487 $3.53 Million
Q3 2021

Nov 15, 2021

BUY
$204.28 - $225.82 $54,542 - $60,293
267 Added 1.88%
14,492 $2.96 Million
Q2 2021

Aug 06, 2021

SELL
$188.43 - $216.47 $61,616 - $70,785
-327 Reduced 2.25%
14,225 $2.94 Million
Q1 2021

May 11, 2021

SELL
$171.2 - $202.81 $489,460 - $579,833
-2,859 Reduced 16.42%
14,552 $2.77 Million
Q4 2020

Feb 02, 2021

SELL
$172.67 - $196.05 $5,698 - $6,469
-33 Reduced 0.19%
17,411 $3.3 Million
Q3 2020

Nov 12, 2020

SELL
$150.16 - $176.19 $66,520 - $78,052
-443 Reduced 2.48%
17,444 $3.07 Million
Q2 2020

Aug 13, 2020

BUY
$137.7 - $165.89 $55,217 - $66,521
401 Added 2.29%
17,887 $2.75 Million
Q1 2020

May 26, 2020

BUY
$107.76 - $168.51 $1.88 Million - $2.95 Million
17,486 New
17,486 $2.45 Million
Q1 2020

May 15, 2020

SELL
$107.76 - $168.51 $2.46 Million - $3.84 Million
-22,789 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$136.92 - $154.3 $108,166 - $121,897
-790 Reduced 3.35%
22,789 $3.47 Million
Q3 2019

Nov 14, 2019

SELL
$141.62 - $155.4 $181,981 - $199,689
-1,285 Reduced 5.17%
23,579 $3.41 Million
Q2 2019

Aug 12, 2019

SELL
$120.49 - $148.88 $60,245 - $74,440
-500 Reduced 1.97%
24,864 $3.7 Million
Q1 2019

May 13, 2019

BUY
$101.48 - $128.03 $2.57 Million - $3.25 Million
25,364 New
25,364 $3.25 Million

Others Institutions Holding STE

About STERIS plc


  • Ticker STE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 100,015,000
  • Market Cap $22B
  • Description
  • STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking prod...
More about STE
Track This Portfolio

Track Bahl & Gaynor Inc Portfolio

Follow Bahl & Gaynor Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bahl & Gaynor Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bahl & Gaynor Inc with notifications on news.